Special Report

These Will Be the Deadliest Cancers in 2023

Ridofranz / iStock via Getty Images

Cancer is the second-most common cause of death in America after heart disease. Nearly 1.9 million new cancer cases are likely to be diagnosed in the United States in 2023, and about 609,820 deaths from cancer are expected here this year, according data provided by the American Cancer Society. The good news is cancer survival rates are rising, although some cancers remain more deadly than others.

To compile a list of the cancers projected to kill the most people in the U.S. this year, 24/7 Tempo reviewed data from the American Cancer Society’s “Cancer Facts and Figures 2023.” Estimated deaths are based on 2006-2020 U.S. mortality data from the National Center for Health Statistics, a division of the Centers for Disease Control and Prevention. Numbers are rounded to the nearest 10. Basal cell and squamous cell skin cancers are excluded because they can often be cured, and data on survival rates is limited. Deaths from colon and rectal cancers are combined because rectal cancer is misclassified as colon cancer.

The five-year relative survival rate for all cancers combined has increased significantly since the mid-1970s to 2018, from 50% to 69% among whites and from 39% to 64% among African-Americans. Advances in treatment and earlier diagnosis for some cancers have raised the cancer survival rate. (These are the most common cancers in America and their survival rate.)

Survival rates vary by cancer type and stage, however, as well as the age of the diagnosed patient. Those with prostate cancer, breast cancer, melanoma of the skin, and lymphoma have the best chance of surviving. Pancreas, stomach, lung and bronchus, and esophagus cancers have the lowest survival rates.

Click here to see the cancers that will kill the most Americans this year

The American Cancer Society notes that, aside from non-melanoma skin cancer, at least 42% of newly diagnosed cancers in the U.S. – about 820,000 cases in 2023 – might have been avoidable. These include cancers caused by tobacco use, excess body weight, alcohol consumption, poor nutrition, and physical inactivity. (These are the states with the most cancer cases linked to alcohol.)

gorodenkoff / Getty Images

20. Soft tissue (including heart)
> Estimated total deaths in 2023: 5,140
> Estimated female deaths in 2023: 2,420
> Estimated male deaths in 2023: 2,720
> 5-year survival rate: 65% – N/A

[in-text-ad]

Pornpak Khunatorn / iStock via Getty Images

19. Other leukemia
> Estimated total deaths in 2023: 5,210
> Estimated female deaths in 2023: 2,060
> Estimated male deaths in 2023: 3,150
> 5-year survival rate: 23.7% – N/A

Malikov Aleksandr / iStock via Getty Images

18. Melanoma of the skin
> Estimated total deaths in 2023: 7,990
> Estimated female deaths in 2023: 2,570
> Estimated male deaths in 2023: 5,420
> 5-year survival rate: 94% – 4th highest among most common cancers

peterschreiber.media / iStock via Getty Images

17. Stomach
> Estimated total deaths in 2023: 11,130
> Estimated female deaths in 2023: 4,440
> Estimated male deaths in 2023: 6,690
> 5-year survival rate: 33% – 5th lowest among most common cancers

[in-text-ad-2]

Dr_Microbe / iStock via Getty Images

16. Acute myeloid leukemia
> Estimated total deaths in 2023: 11,310
> Estimated female deaths in 2023: 4,870
> Estimated male deaths in 2023: 6,440
> 5-year survival rate: 31.7% – N/A

Shidlovski / iStock via Getty Images

15. Myeloma
> Estimated total deaths in 2023: 12,590
> Estimated female deaths in 2023: 5,590
> Estimated male deaths in 2023: 7,000
> 5-year survival rate: 58% – 16th highest among most common cancers

[in-text-ad]

Ivan-balvan / iStock via Getty Images

14. Uterine corpus
> Estimated total deaths in 2023: 13,030
> Estimated female deaths in 2023: 13,030
> Estimated male deaths in 2023:
> 5-year survival rate: 81% – 7th highest among most common cancers

Raycat / Getty Images

13. Ovary
> Estimated total deaths in 2023: 13,270
> Estimated female deaths in 2023: 13,270
> Estimated male deaths in 2023:
> 5-year survival rate: 50% – 7th lowest among most common cancers

Nerthuz / Getty Images

12. Kidney and renal pelvis
> Estimated total deaths in 2023: 14,890
> Estimated female deaths in 2023: 4,970
> Estimated male deaths in 2023: 9,920
> 5-year survival rate: 77% – 9th highest among most common cancers

[in-text-ad-2]

Dr_Microbe / iStock via Getty Images

11. Esophagus
> Estimated total deaths in 2023: 16,120
> Estimated female deaths in 2023: 3,200
> Estimated male deaths in 2023: 12,920
> 5-year survival rate: 21% – 3rd lowest among most common cancers

wildpixel / Getty Images

10. Urinary bladder
> Estimated total deaths in 2023: 16,710
> Estimated female deaths in 2023: 4,550
> Estimated male deaths in 2023: 12,160
> 5-year survival rate: 77% – 8th highest among most common cancers

[in-text-ad]

simonkr / E+ via Getty Images

9. Brain and other nervous system
> Estimated total deaths in 2023: 18,990
> Estimated female deaths in 2023: 7,970
> Estimated male deaths in 2023: 11,020
> 5-year survival rate: 33% – 6th lowest among most common cancers

Hailshadow / iStock via Getty Images

8. Non-Hodgkin lymphoma
> Estimated total deaths in 2023: 20,180
> Estimated female deaths in 2023: 8,400
> Estimated male deaths in 2023: 11,780
> 5-year survival rate: 74% – 10th highest among most common cancers

Dr_Microbe / Getty Images

7. Lymphoma
> Estimated total deaths in 2023: 21,080
> Estimated female deaths in 2023: 8,760
> Estimated male deaths in 2023: 12,320
> 5-year survival rate: 89% – 6th highest among most common cancers

[in-text-ad-2]

Ozgu Arslan / iStock via Getty Images

6. Liver and intrahepatic bile duct
> Estimated total deaths in 2023: 29,380
> Estimated female deaths in 2023: 10,380
> Estimated male deaths in 2023: 19,000
> 5-year survival rate: – 21% – 2nd lowest among most common cancers

jamesbenet / E+ via Getty Images

5. Prostate
> Estimated total deaths in 2023: 34,700
> Estimated female deaths in 2023: 34,700
> Estimated male deaths in 2023:
> 5-year survival rate: 97% – 2nd highest among most common cancers

[in-text-ad]

Povozniuk / iStock via Getty Images

4. Breast
> Estimated total deaths in 2023: 43,700
> Estimated female deaths in 2023: 43,170
> Estimated male deaths in 2023: 530
> 5-year survival rate: 91% — 5th highest among most common cancers

yodiyim / Getty Images

3. Pancreas
> Estimated total deaths in 2023: 50,550
> Estimated female deaths in 2023: 23,930
> Estimated male deaths in 2023: 26,620
> 5-year survival rate: — 12% — the lowest among most common cancers

Liudmila Chernetska / iStock via Getty Images

2. Colon and rectum
> Estimated total deaths in 2023: 52,550
> Estimated female deaths in 2023: 24,080
> Estimated male deaths in 2023: 28,470
> 5-year survival rate: 65% – 10th lowest among common cancers

[in-text-ad-2]

utah778 / Getty Images

1. Lung and bronchus
> Estimated total deaths in 2023: 127,070
> Estimated female deaths in 2023: 59,910
> Estimated male deaths in 2023: 67,160
> 5-year survival rate: 23% – 4th lowest among most common cancers

The #1 Thing to Do Before You Claim Social Security (Sponsor)

Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.

A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.

Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.

 

Have questions about retirement or personal finance? Email us at [email protected]!

By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.

By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.